|
||
J. Exp. Med.,
Volume 188, Number 5, September 7, 1998 877-886
By






From the * Harold C. Simmons Arthritis Research Center and Department of Internal Medicine; Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known. B27 transgenic rats develop a spontaneous disease resembling the human spondyloarthropathies that includes arthritis
and colitis. To investigate whether this disease requires the binding of specific peptides to B27,
we made a minigene construct in which a peptide from influenza nucleoprotein, NP383-391
(SRYWAIRTR), which binds B27 with high affinity, is targeted directly to the ER by the signal peptide of the adenovirus E3/gp19 protein. Rats transgenic for this minigene, NP1, were made and bred with B27 rats. The production of the NP383-391 peptide in B27+NP1+ rats
was confirmed immunologically and by mass spectrometry. The NP1 product displaced ~90%
of the 3H-Arg-labeled endogenous peptide fraction in B27+NP1+ spleen cells. Male
B27+NP1+ rats had a significantly reduced prevalence of arthritis, compared with B27+NP
Howard Hughes Medical Institute and Department of Biochemistry; § Department of Pediatrics and
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75235; ¶ Department of Chemistry, UMIST, Manchester, United Kingdom; ** Micromass Ltd, Wythenshawe,
Manchester, United Kingdom; and the 
Department of Medicine, University of North Carolina,
Chapel Hill, North Carolina 27599
males or B27+ males with a control construct, NP2, whereas colitis was not significantly affected by the NP1 transgene. These findings support the hypothesis that B27-related arthritis
requires binding of a specific peptide or set of peptides to B27, and they demonstrate a method
for efficient transgenic targeting of peptides to the ER.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|